NFB implemented successfully most activities defined in the application for financing during the third year of the project and by doing so accomplished significant progress in achieving overall objectives of the project.
The ALSEOS line with a capacity of 150L was built in compliance with food standards. The entire line is located in one space in the Research Organization (Bionanopark). The pilot facility has been designed and delivered samples for regulatory purposes. we have implemented the GMP and HACCP standards.
Thanks to this the obtained samples of protein products were sent to external laboratories and tested there. Documents for reporting Raptein 90 and Raptein 30 for registration of Novel Food (EU) and GRAS (US) have been prepared. The dossier documents were submitted and are currently under revision by the FDA and EFSA.
We conducted application tests of Raptein 30 and Raptein 90 in various formulations/applications:
Plant-based drink, plant-based yogurt alternative, and Plant-based drink from powder (RTM - Ready To Make) gluten-free bread.
The line is ready to deliver larger quantities of protein products that will be required for precommercial trials to be performed by NFB go-to-market partners and prospective customers from the food industry.
Thanks to the tests carried out in WP1 and WP2, the NFB team, supported by the selected contractor A / E (Architect / Engineering) PM Group (Birmingham GB / Wrocław PL), developed the concept of the Rapeseed Bio-refinery. These efforts resulted in a complex Biorefinery Engineering Design (CED) package that will be offered to potential NFB technology licensees as an integral part of the technology transfer package.
The main deliverables in the package are user requirement specifications for the feedstock material, ,mass and energy balances for the production process, also CAPEX and OPEX calculations for the different process configurations and production scales. Information contained in the CED package will enable the prospective licensee to make an initiated investment decision.
The 2000L pilot line located in Żórawina was prepared and approved as planned. The NFB performed preparatory works, incl. ordering and qualification of raw materials.
NapiFeryn applied for the worldwide patent protection of the 3rd and 4th IP packages generated during the project (PCT/EP2019/069113).
Protecting our unique value proposition will enable the implementation of the business model based on licensing of our technology to selected partners operating on a global scale. Furthermore, we prepared the Commercialization Plan and defined the objectives for the successful commercialization of our technology package.
We prepared and realized a Communication Plan that enables us to effectively communicate about the project and its benefits to multiple audiences.
We have established contact with rapeseed processors (potential users of the technology) who have their headquarters in Europe, the USA Canada, or Australia and we are conducting talks with global rapeseed processing plants integrated with distribution possibilities.
